Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based anticancer therapy: Tumor suppressor MiRNA-203 suppresses the expression L1CAM via down regulation of its target genes, 19/February/2015, 21.45, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that tumor suppressor MiRNA-203, by decreasing the expression of its target gene, it may inhibit the expression of L1CAM. Thereby, it may inhibit migration and invasion of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-203 activators” can be used to inhibit metastatic human tumors.
Amount: $ 300
Undisclosed information: How MiRNA-203 suppresses the expression of L1CAM.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
